Stem Cell Therapy as an Alternative to Reconstruction of Complete ACL Tears and Associated Physical Therapy Considerations – A Case Report by Broderick, Andrew
Doctor of Physical Therapy Program Case 
Reports Physical Therapy and Rehabilitation Science 
Fall 2019 
Stem Cell Therapy as an Alternative to Reconstruction of 
Complete ACL Tears and Associated Physical Therapy 
Considerations – A Case Report 
Andrew Broderick 
University of Iowa 
Follow this and additional works at: https://ir.uiowa.edu/pt_casereports 
 Part of the Physical Therapy Commons 
Copyright © 2019 Andrew Broderick 
Hosted by Iowa Research Online. For more information please contact: lib-ir@uiowa.edu. 
  2019 Broderick, Andrew 
  
1 
Stem Cell Therapy as an Alternative to Reconstruction of Complete ACL Tears and Associated 





DPT Class of 2019 
Department of Physical Therapy & Rehabilitation Sciences 




Introduction: Injury to the anterior cruciate ligament (ACL) is one of the most common injuries in 
orthopedics and sports medicine. With nearly 200,000 injuries per year in the United States, 100,000 
opt for reconstructive surgery. There are a variety of known graft choices including hamstring, patellar 
tendon, quadriceps tendon, IT band, and allogenous grafts. However, these options do not come 
without future complications. Regenerative medicine using stem cell therapies is becoming increasingly 
popular. Thus, the purpose of this case report is to highlight the use of stem cell therapies as an 
alternative treatment to traditional ACL reconstruction, and to provide insight to its associated physical 
therapy progression. Case description: The rehabilitation of a 26-year-old female with a grade III ACL 
tear that was less than one cm retracted with goals of returning to an active lifestyle is described. 
Outcomes: MR imaging was assessed at three months which indicated healing of the ACL. Lower 
Extremity Functional Scale (LEFS) scores increased from 23/80 to 68/80 over the course of 7 months. 
Other potentially useful outcomes measures are discussed. Discussion: Based on the current 
literature, regenerative medicine using stem cell therapies seems to be a promising alternative to 
surgical treatment of the ACL. Slight differences exist between rehab of the ACL treated with stem cell 
therapy vs traditional reconstruction. Although subjective reports of knee pain and function improve 
over time, more objective measurements to quantify ACL healing are needed. Future research aimed at 
determining long term effects of stem cell therapies is warranted.  
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Introduction 
 Injury to the anterior cruciate ligament (ACL) is one of the most common injuries in orthopedics 
and sports medicine. In the United States, nearly 200,000 injuries occur per year with nearly 100,000 of 
these individuals opting for ACL reconstructive surgery (ACLR).1 There are a variety of known 
techniques to surgically reconstruct this ligament and facilitate return to both recreational and 
competitive activity. However, the risk of future complications as a result of altered knee biomechanics 
and inability to return to full activity are relatively high. Following ACL reconstruction, it has been shown 
to lead to increased anterior position of the tibia and increased internal rotation of the tibia at one-year 
post ACLR. A result of these altered biomechanics would place more load through the medial 
compartment, which may be a factor in the increased rate of medial compartment osteoarthritis (OA) 
after ACLR.2 The risk of developing future knee OA increases dramatically when the initial injury is 
paired with a meniscal or chondral lesion.3 To be considered successful with ACLR, the individual 
should be able to return to the same level of activity as before the injury occurred. After ACLR, an 
average of 81% of individuals return to any form of sport, 65% return to pre-injury levels, and only 55% 
returned to competitive levels.4,5 This rather low return to play rate may be due to a variety of factors 
associated with reconstruction of the ACL. An alternative intervention that serves to be less invasive 
and does not alter the biomechanics of the knee joint is needed.  
There are 5 different graft options available to be used in reconstruction of the ACL: hamstring, 
patellar tendon, quadriceps tendon, IT band, and allogenous cadaveric grafts. Allogenous grafts are 
less common and will not be discussed. Although all of these options have shown to provide increased 
stability to the knee joint, they do not come without limitations. Poor proprioceptive awareness, 
muscular weakness, donor harvest morbidity, inability to restore normal kinematics, and the potential of 
early onset osteoarthritis are common complications.6 
Hamstring autografts include harvesting from the semitendinosus tendon. When a double-
bundle hamstring graft is used, both the semitendinosus and gracilis tendons are harvested. Hamstring 
complications include strength deficits in knee flexion and internal rotation, and it’s been suggested 
there is a potential for higher re-rupture rates. This may be due to the lack of a bony plug leading to 
less osteointegration between graft and bone.7  
Patellar tendon autografts include harvesting bone plugs from both the distal aspect of the 
patella and the tibial tubercle, and 1/3 the width of the patellar tendon. Higher osteointegration rates are 
seen, likely due to the use of two bone plugs leading to more stability of the graft. Complications include 
an increased risk of developing anterior knee pain, patellar tendinopathy, and increased subsequent 
operations for meniscal or chondral lesions, contralateral ACL tears, greater motion loss, and lower 
clinical outcomes are demonstrated. It is suggested that the prevalence of early onset osteoarthritis is 
greater with this technique vs the use of a hamstring graft.8-10 
Quadriceps tendon autograft harvesting includes a bone plug from the proximal portion of the 
patella and a graft from the quadriceps tendon to include fibers from vastus lateralis, vastus medialis, 
vastus intermedius, and rectus femoris. The bone plug allows for greater fixation and when combined 
with a thick graft has the potential to serve a reliable graft choice without the development of anterior 
knee pain or decreased strength deficits as in the patellar tendon graft and hamstring grafts, 
respectively. Complications include quadriceps strength inhibition and strength deficits. This is a 
relatively new method and continued research is needed.11 
The IT band autograft is a graft choice that is used when there is a need to prevent drilling 
through unclosed growth plates, such as in pre-pubescent adolescents. This technique is called 
“extraphyseal” or “physeal-respecting” where the surgeon uses the IT band as the graft and either 
avoids drilling into the physis completely or compromises only a small physeal area. This procedure 
has been associated with excellent functional outcomes, low risk of re-rupture rate, and minimal mid-to-
long term complications.12  
 There are a variety of techniques and graft choices to use when reconstructing the ACL, 
however the risk of developing future complications is relatively high. Many of these complications are 
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due to the nature of invasiveness with surgical procedures, or a result of deficits caused by graft 
harvest. Stem cell therapies may serve as an effective alternative treatment to return integrity to the 
ACL after partial or complete tears that does not require invasive surgical techniques, such as those 
used with ACL reconstruction.  As a result, they have the potential to not disturb the biomechanics of 
the knee joint and may decrease the risk of early degenerative changes to surfaces of both the 
tibiofemoral and patellofemoral joints. The purpose of this case report is to highlight the use of stem cell 
therapies as an alternative treatment to traditional ACL reconstruction, and to provide insight to its 
associated physical therapy progression.  
 
Case Description 
 Patient A is a 26-year-old female who presents to an outpatient physical therapy clinic following 
a stem cell injection of her left knee in an attempt to regenerate a full-thickness ACL tear. The date of 
injury will be referred to as “day 1.” She incurred the ACL tear through a non-contact mechanism when 
she was skiing and reports there was no fall, she just turned, and her knee felt funny. She had never 
had a knee injury before, but there was an audible “pop” sensation that she describes as a rubber band 
snapping and she knew something was wrong. After she heard the “pop”, there wasn’t much pain 
involved – something just didn’t feel right. She was able to continue skiing for a couple more hours, but 
the knee kept “giving out” so she decided to be done for the day. Fortunately, a close friend of hers was 
a physician and she was able to get scheduled for an MRI to take place on the following day. The MRI 
report showed a grade III full thickness tear of the ACL that was less than one cm retracted. As an 
active young female, her goals were to return to skiing, trail running, high intensity interval training 
(HIIT) workouts, swimming, rock climbing, etc. As innovative methods such as regenerative medicine 
become increasingly feasible and promising as a first line treatment, this warrants the need for physical 
therapists to be aware of these procedures and their rehabilitation considerations. Although limited, 
there has been evidence to support success in treating symptomatic patients with grade 1, 2, and 3 
tears, as long as the ligament retraction is less than one cm.13,14   
Patient A had the stem cell procedure on day 7 and followed up her physical therapy evaluation 
on day 14. To assist with gait, she was using bilateral axillary crutches with orders per the physician to 
weight bear as tolerated. Her left knee was slightly swollen, graded as 1+ during the time of the initial 
evaluation. Overall her motion was great – she had full knee flexion and extension, with slight 
discomfort in the fully extended position which she rated as a 4/10. When assessing strength, her left 
leg was slightly weaker at 4+/5 globally compared to 5/5 on the right. Due to relationship of muscle 
inhibition and swelling, neuromuscular re-education exercises were given to facilitate activation of the 
muscles in the lower extremity which included heel slides, quad sets, and double leg bridging. Towards 
the end of her evaluation, time was spent educating her on the rationale behind stem cell procedures, 
relevant anatomy, and a timeline for her return to more vigorous activity. Additional education was 
given as it relates to stem cell procedures, making sure she did not take anti-inflammatories, blood 
thinners, or use ice excessively for the first 6 weeks as it may inhibit the inflammatory response needed 
to maintain an environment that allows the stem cells to remodel the damaged ACL.  
She was then seen 2 times per week for the first month to work on light strengthening and 
gentle balance training. For additional stability, she used a typical post-operative ACL brace for 4-6 
weeks. Since her range of motion was within normal limits and there were no graft harvesting sites, she 
was able to use the bike and elliptical as tolerated as long as the brace was in place for cardiovascular 
exercise. It was recommended to jog in the pool using a flotation belt with water up to the chest for 30-
45 minutes 3-5x/week to keep the knee moving without much load at the knee joint. She was able to 
progress the strengthening exercises, and now those included continued quad sets increasing the 
number of repetitions, heel slides, standing hip abduction, weight shifts, and various core exercises that 
did not stress the lower extremity. As she progressed over the next 4 weeks, she was able to initiate 
mini-squats, lateral lunges with conservative distance emphasizing proper mechanics, standing swiss 
ball terminal knee extension, banded work including side steps, diagonal steps, step downs less than 
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60 degrees of knee flexion, and bridge progressions. As a general rule, if the activity was more than 
2/10 on a pain scale or if there was any instability, then the activity needed to be modified or changed.  
She was then seen 4 times over the next 2 months to work on progressing the strengthening 
and balance exercises. During this period, she no longer needed to wear the brace unless she was 
attempting hikes with uneven ground. The leg press was utilized to work on double and single leg 
strength and control, avoiding more than 60 degrees of knee flexion to minimize shear forces on the 
ACL.15,16 Progression of banded work to target hip abductor strengthening, single leg exercises, and 
balance were implemented to work on neuromuscular control. As the patient approached week six, 
impact progressions such as hops, leaps, and jumps were used to return to sagittal plane jogging. At 
this time the patient had complaints of “clicking” in the knee, but it was not associated with any pain. 
The patient returned to straight line jogging at about the 3-month mark. At this time the patient had a 
scheduled follow-up MRI that demonstrated the ACL was healing, which was required by the physician 
to move on to the next phase of rehab. Two other benchmarks that were required to progress were 
single leg balance for 60 seconds (eyes closed, preferably), and 20 repetitions of a single leg squat to 
60 degrees of knee flexion.  
She was then seen 6 times over the 4 months to work on sport specific exercises and return to 
full recreational activities. She was instructed to use an ACL brace when initiating cutting exercises and 
for other recreational activities that including lateral movements. During this time, her main goal was to 
be able to hike a 14er (a mountain peak higher than 14,000 feet of elevation) without feeling fatigued 
when going downhill. Impact exercises with an emphasis on eccentric control and soft-landing 
mechanics were implemented. Exercises including single leg ball drop into squat, single leg drop steps, 
single leg bosu pistol squats, reactive directional changes, dynamic warmups, etc. were utilized. At 7 




 At the local physician’s clinic where the stem cell injections were performed, MRI grey scale 
measurements were analyzed in order to assess signal intensity of the ACL. Using a software called 
ImageJ, the physicians were able to obtain quantitative changes where a lower value was indicative of 
a darker image, correlating with increased ligament density. In this case report, the patient underwent 
an MRI at 3-months following the stem cell injection. Clearance was given to progress with physical 
therapy. Although the MRI provided insight, the findings cannot be fully extrapolated to the actual 
integrity of structures within the knee joint. Yang et al. performed a meta-analysis comparing MRI vs the 
gold standard of arthroscopy for diagnosing ACL injuries, and found a specificity of .9 and a sensitivity 
of .87.17 In other words, a positive test is incorrect in 10% of cases and a negative test is incorrect in 
13% of cases. Another method to assess integrity of the ACL is the KT-1000, which objectively 
measures the anteroposterior displacement of the tibiofemoral joint. Since the healing time frame 
following stem cell injections are relatively variable and unknown, this assessment may place unwanted 
loads upon the ACL and may not be an appropriate outcome measure to assess ligament integrity.  
Functional outcome measures were used in the physical therapy clinic as well. The Lower 
Extremity Functional Scale (LEFS) is a questionnaire that is 20 questions regarding the patient’s ability 
to perform everyday tasks and serves as a tool to measure progress over time. It is a scale from 0-80, 0 
indicating greater disability and 80 indicating no disability. At the patient’s initial evaluation, she 
reported a score of 23. At 5 weeks, she reported a score of 56. At 14 weeks, she reported a score of 
65. At 18 weeks, she reported a score of 68. With a score of 68/80, the patient indicated that she was 
85% fully functional. The capacity of the LEFS to detect change in lower extremity function is superior 
when compared with other outcome measures, with the error associated with a given measure on the 
LEFS at +/- 5 points. The minimal detectable change and minimal clinically important difference are 
both set at 9 points.18 Her 45 point change over the 18 visits clearly exceeded both error and minimal 
change metrics.  
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Patient reported improvements in function are arguably the most important aspect of patient 
care. Measures such as the International Knee Documentation Committee (IKDC) questionnaire and 
the Numeric Pain Scale (NPS) would have been useful in this case study in order to obtain more 
subjective information regarding how the patient felt they were progressing over time. In patients who 
had partial and full thickness tears of the ACL, Centeno et al. demonstrated improvements with the 
IKDC at all time points (1 month to 36 months) and improvements in the NPS at nearly all time points 
(1-24 months) in patients who were treated with stem cell therapies.14 This is represented in Table 1. 
 
Table 1. Subjective outcome measures monitored over 36 months in patients with ACL stem 
cell injections. First number indicates the average score reported and the second is the 
number of subjects who responded, indicated by parenthesis. This table is adapted from 
Centeno et. Al. (2018) 
 





 25.0 (14) 65.3 (19) 75.5 (19) 66.7 (21) 78.8 (16) 82.6 (17) 88.8 (8) 
NPS 
 
2.5 (25) 1.9 (15) 1.8 (20) 1.0 (19) 1.4 (19) 1.1 (16 .8 (18) 1.0 (8) 
LEFS 
 
51.1 (23) 61.4 (14) 65.7 (19) 72.0 (19) 72.2 (19) 74.1 (16) 75.9 (17) 72.6 (8) 
IKDC 
 
53.4 (20) 67.6 (14) 72.9 (18) 82.4 (18) 83.7 (16) 83.7 (16) 87.0 (18) 87.9 (8) 
SANE: Single Assessment Numeric Evaluation; NPS: Numeric Pain Scale; LEFS: Lower Extremity Functional Scale; IKDC: 
International Knee Documentation Committee 
 
Discussion 
The purpose of this case report was to highlight the use of stem cell therapies as an alternative 
treatment to traditional ACL reconstruction, and to provide insight to its associated physical therapy 
progression. As previously stated, there is evidence to support success in treating grade 1, 2 and 3 
tears with less than 1 cm retraction.13,14 Although protocols vary by physician, typically the first step in 
the injection protocol is to administer a pre-injection of a hypertonic dextrose solution into the ACL 2-5 
days prior to the injection of the bone marrow concentration (BMC). The purpose of this pre-injection is 
to provide a chemical irritant to the ACL with aims to promote a brief inflammatory response. This is 
why it’s important to avoid anti-inflammatories for 6 weeks and excessive icing during the first 7 days. 
The next step is to harvest bone marrow from the patient and isolate the mesenchymal stem cells. 
Using fluoroscopic guidance, the bone marrow is extracted from the patient’s iliac crest. Once 
completed, venous blood is drawn and used to isolate a platelet rich plasma (PRP) and platelet lysate 
(PL). After the harvest, the reinjected solution consists of equal parts of BMC, PRP, and PL and is 
injected directly into the ligament. When withdrawing from the ligament and still within the joint capsule, 
the remaining BMC, PRP, and PL is injected.13  
There are three different types of stem cells: embryonic, induced pluripotent, and mesenchymal. 
These are summarized in Table 2. Embryonic and induced pluripotent stem cells are both considered 
pluripotent stem cells. As a result, they have the capacity to differentiate into all three germ layers: 
ectoderm, endoderm, and mesoderm. The ectoderm gives rise to the different skin layers and the 
central nervous system. The endoderm gives rives to the inner organ systems including the digestive 
and respiratory tubes. The mesoderm gives rise to cells that form bone, cartilage, muscle, adipose and 
synovial tissue.19 Mesenchymal stem cells (MSC) are considered multipotent, resulting in a more 
limited differentiation capacity as they are farther down the lineage. These stem cells only have the 
capacity to differentiate into cells of mesodermal origin which include bone, cartilage, and muscle, and 
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adipose. Due to the high differentiation capacity (i.e. ability to turn into all three germ layers) of both 
embryonic and induced pluripotent stem cells, these are considered oncogenic as there is a 
significantly higher risk of these cells developing into cancerous cells.20 When taking these factors and 
the ease of harvest into consideration, this is why mesenchymal stem cells have become the preferred 
stem cell choice in the treatment of musculoskeletal conditions.  
 
Table 2: Overview of the different types of stem cells with source, advantages, and 
disadvantages. Note: table adapted from Saltzman et al. 
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 Mesenchymal stem cells can be isolated from a number of different tissue sources including 
bone marrow, synovium, periosteum, muscle, and adipose.19 This is summarized in Table 3.  Although 
there are several tissue sources to obtain the mesenchymal stem cells, each tissue sources leads to 
MSC with varying characteristics and differing proliferation capabilities. For example, the synovium and 
bone marrow have the highest proliferation potential, meaning they are able to proliferate for the 
longest period of time resulting in the most cells. When evaluating chondrogenesis, bone marrow, 
synovium, and periosteum led to the largest increase in chondrocyte pellet size and increases in 
extracellular matrix composition. Furthermore, adipocytes had the lowest proliferation potential. Due to 
the nature of different tissue sources leading to different characteristics, mesenchymal stem cells 
derived from bone marrow have become the preferred choice due to the relative ease of harvest and 
more optimal outcomes.19 
Often times, stem cells are used in adjunct with platelet rich plasma (PRP) and platelet lysate 
(PL) injections. Although PRP and PL are outside the scope of this case report, they are discussed 
briefly for completeness. After obtaining a blood draw, a centrifuge machine is used to obtain a 
concentration very rich in platelets. These platelets produce a very large number of biologic factors 
including growth factors (PDGF, TGF-B, IGF-1, VEGF), cytokines, proteins, and extracellular 
components. PL is formed via “freeze-thaw” method, where the concentration rich in platelets is cooled 
down to -20C, and when they begin to thaw, they release the abundant biologic factors. PRP releases 
these components over the course of a week and PL is more of an immediate release, however both of 
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these adjuncts are used to augment the effect of the mesenchymal stem cells. The reported effects are 
increased proliferation of mesenchymal stem cells, increased ability to maintain differentiation capacity 
into osteoblasts, chondrocytes, etc., and increased immunosuppressive properties. 21,22 
  
Table 3. Summary of mesenchymal stem cell sources. Note: table adapted from Saltzman 
et al. (2016) 
 
MSC Source Differentiation potential Advantages 
Bone Marrow Chondrocyte, muscle, 
osteoblast, cardiocyte, 
mesangial cell, hepatocyte 
Highest differentiation potential 
Adipose Chondrocyte, muscle, 
osteoblast, stromal cell 
Easily accessible, higher colony 
formation compared to bone 
marrow derived cells 
Synovium Adipocyte, chondrocyte, 
muscle, osteoblast 
Applicable for cartilage and 
tendon healing 
Periosteum Chondrocyte, osteoblast Applicable to fracture nonunion 
healing 
 
Although still limited, there is slightly more literature involving partially torn ACLs. In animal 
studies, partially torn ACLs applied with intra-articular BM-MSC demonstrated repaired tissue whereas 
the group with no injection demonstrated further retraction and no repair. Another study found that 
when the medial halves of the ACLs were transected and applied with BM-MSC that histological and 
biochemical outcomes were almost the same as normal uninjured ACLs at 4 weeks.23,24 This case 
report progression is consistent with other studies of the same intervention. Centeno et al. found that 
77% of patients treated with BMC into the ACL demonstrated improvements in ACL integrity at 8.8 
months and improvement in LEFS scores at all time points compared to baseline.14 
Stem cell therapies have also been used as an adjunct in ACLR and used to treat other 
orthopedic conditions such as knee osteoarthritis, rotator cuff (RTC) tears, and discogenic low back 
pain. Recently, Chen et. al. demonstrated that when BMC was injected at the time of ACLR there was 
an increase in the amount of a myofibroblast termed smooth muscle actin positive (SMA+). This 
myofibroblast increases the number of growth factors and proteins in the ECM, helps form sharpey’s 
fibers, and promotes a denser formation of collagen in the ligament. Sharpey’s fibers are a sign of 
osteointegration, which is a hallmark of healing between soft tissue and bone. Not only was the 
collagen denser, but it had a more orderly arrangement that ultimately led to increased ligamentization 
and higher stiffness in the ligament. Additionally, there was decreased bone tunnel areas and increased 
bone volume in both the femur and tibia, which leads to better graft fixation.25 For knee OA, MSC have 
demonstrated potent anti-inflammatory properties, improved cartilage, and improved quality of life 
outcomes at one year post-injection. The process of allocating stem cells is called “homing.” This is 
followed by differentiation and proliferation, regeneration of the damaged tissue, and then healing of the 
intraarticular cascade.26 Additionally, stem cells influence natural killer cells, macrophages, and 
lymphocytes and act to inhibit their proliferation, chemiotaxis, and promote cytotoxic action of immune 
cells.26 When MSC are used for the treatment of RTC tears, they’ve been shown to decrease the 
amount of fatty infiltrate, create a more elastic bone repair at the bone-tendon interface, and decrease 
inflammation.26 Lastly, there are three major mechanisms by which MSC act to ameliorate discogenic 
low back pain. First, they act to slow or reverse the catabolic process by secreting anabolic growth 
factors. Second, they aim to restore the disk tissue by promoting the synthesis of type II collagen and 
proteoglycans. Thirdly, they act to decrease the primary nociceptive disk pain by restoring the 
mechanical support and stopping the inflammatory milieu that lead to increased nerve growth in the first 
place.26  
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However, positive outcomes have been recorded following rehabilitation of ACL-deficient knees 
as well.14,27 It is difficult to determine whether the success of this case report was due to the stem cell 
injections regenerating the ACL, or whether these outcomes would have been recorded if she would 
have chosen no intervention other than conservative rehabilitation alone. It is also not clear whether the 
injected MSCs are directly participating in repairing the tissue by biochemical synthesis, or whether 
they are activating a cascade of events that eventually leads to the repair by modulating tissue through 
fostering an ideal environment. Additionally, cell-based therapies are typically applied by percutaneous 
intra-articular injections of autologous BMC, which will have additional components other than the MSC. 
Thus, it is difficult to say what precisely is the key ingredient. When looking at objective tests, the 
majority of studies in humans are using MR imaging to extrapolate density of the ligament. There are a 
variety of factors that go into determining signal intensity of MRIs when comparing pre and post, and 
discrepancies in this process may bias results. The lack of objective anterior laxity measurements of 
studies in the current literature make it difficult to determine that even if the ligament has undergone a 
remodeling process, that this process leads to protection of excessive anterior translation of the tibia. 
The literature is growing and the use of stem cells for treatment of orthopedic conditions becomes an 
increasingly favorable alternative. However,  due to the nature of small sample sizes and limited 
randomized controlled trials, the research of stem cell injections specific to the regeneration of the ACL 
must be interpreted with caution as publication bias may be present.20 Although it is a great place to 
start, most of the data at this time is from uncontrolled registry studies or case series published by the 
physicians who injected the BMC, and as a result the data must be interpreted with caution. Another 
factor to consider is the age of the patient – this case report focused on a 26-year-old female who was 
overall very healthy and had no limiting psychosocial factors. The differentiation capacity of stem cells 
may not be same with increasing age, and thus patient selection for these types of operations may be 
very important. Lastly, the financial cost associated with stem cell therapy is very high. At this stage, 
insurance does not cover these procedures. In order to get stem cell therapy, you must meet the 
inclusion criteria to be involved with a research study or you must pay out of pocket, with current 
estimates ranging from $5,000-$12,000. As a result, most of the data comes from studies who have 
strict inclusion criteria (healthy, no other knee injuries, etc.) and so this data should not be extrapolated 
to the general population.  
Future research geared towards post injection biochemical analyses of both intra-articular 
environment changes as well as intra-ligament environment changes may help provide insight to the 
mechanisms by which stem cell therapy acts for musculoskeletal conditions and may help determine 
the appropriate subset of individuals where this is most advantageous. Mid to long term follow up 
studies monitoring overall health and function are needed as they may provide insight to potential 
negative consequences of MSC injections (i.e., cancer) or if this more conservative alternative mitigates 
the risk of developing early onset osteoarthritis. As the use of stem cell therapies increases this will 
provide further insight to appropriate timelines of ligamentization, which will allow physical therapists to 
get a better understanding of appropriate progressions for ACL rehabilitation.  
Overall, MSC injections seem to be a promising alternative treatment to regain integrity to the 
ACL without undergoing surgical interventions. This may potentially decrease the risk of future 
complications such as strength imbalances and early onset osteoarthritis, as knee biomechanics are 
preserved. The limited research regarding ACL regeneration using stem cell therapies need to be 
interpreted with caution as it is not well controlled and sample sizes are small. As stem cell therapies 
for orthopedic conditions become more common, this case report serves as an example of 
rehabilitation time frames for an individual treated with MSC for a full thickness ACL tear that was less 
than one cm retracted. Time frames presented in this case report are very similar to guidelines for other 
ACL reconstruction methods, with special attention being paid to anti-inflammatories, ice, and 
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